Literature DB >> 22191450

Salmonella enterica as a vaccine carrier.

Wael Abdel Halim Hegazy1, Michael Hensel.   

Abstract

Salmonella enterica is an invasive, facultative intracellular gastrointestinal pathogen causing human diseases such as gastroenteritis and typhoid fever. Virulence-attenuated strains of this pathogen have interesting capacities for the generation of live vaccines. Attenuated live typhoidal and nontyphoidal Salmonella strains can be used for vaccination against Salmonella infections and to target tumor tissue. Such strains may also serve as live carriers for the development of vaccination strategies against other bacterial, viral or parasitic pathogens. Various strategies have been developed to deploy regulatory circuits and protein secretion systems for efficient expression and delivery of foreign antigens by Salmonella carrier strains. One prominent example is the use of type III secretion systems to translocate recombinant antigens into antigen presenting cells. In this review, we will describe the recent developments in strategies that utilize live attenuated Salmonella as vaccine carriers for prophylactic vaccination against infectious diseases and therapeutic vaccination against tumors. Considerations for generating safe, attenuated carrier strains, designing stable expression systems and the use of adjuvants for live carrier strategies are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22191450     DOI: 10.2217/fmb.11.144

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  18 in total

1.  Tc52 amino-terminal-domain DNA carried by attenuated Salmonella enterica serovar Typhimurium induces protection against a Trypanosoma cruzi lethal challenge.

Authors:  Marina N Matos; Silvia I Cazorla; Augusto E Bivona; Celina Morales; Carlos A Guzmán; Emilio L Malchiodi
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

Review 2.  New technologies in developing recombinant attenuated Salmonella vaccine vectors.

Authors:  Shifeng Wang; Qingke Kong; Roy Curtiss
Journal:  Microb Pathog       Date:  2012-11-08       Impact factor: 3.738

Review 3.  Salmonella as a vaccine delivery vehicle.

Authors:  Kenneth L Roland; Karen E Brenneman
Journal:  Expert Rev Vaccines       Date:  2013-09       Impact factor: 5.217

4.  A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.

Authors:  James E Galen; Jin Yuan Wang; Jose A Carrasco; Scott A Lloyd; Gabriela Mellado-Sanchez; Jovita Diaz-McNair; Olga Franco; Amanda D Buskirk; James P Nataro; Marcela F Pasetti
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

5.  Mucosal immunization with an attenuated Salmonella vaccine partially protects white-tailed deer from chronic wasting disease.

Authors:  Fernando Goñi; Candace K Mathiason; Lucia Yim; Kinlung Wong; Jeanette Hayes-Klug; Amy Nalls; Daniel Peyser; Veronica Estevez; Nathaniel Denkers; Jinfeng Xu; David A Osborn; Karl V Miller; Robert J Warren; David R Brown; Jose A Chabalgoity; Edward A Hoover; Thomas Wisniewski
Journal:  Vaccine       Date:  2014-12-21       Impact factor: 3.641

6.  Live attenuated S. Typhimurium vaccine with improved safety in immuno-compromised mice.

Authors:  Balamurugan Periaswamy; Lisa Maier; Vikalp Vishwakarma; Emma Slack; Marcus Kremer; Helene L Andrews-Polymenis; Michael McClelland; Andrew J Grant; Mrutyunjay Suar; Wolf-Dietrich Hardt
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

7.  Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice.

Authors:  Vikalp Vishwakarma; Niladri Bhusan Pati; Himanshu Singh Chandel; Sushree Sangeeta Sahoo; Bhaskar Saha; Mrutyunjay Suar
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

8.  Engineering the type III secretion system in non-replicating bacterial minicells for antigen delivery.

Authors:  Heather A Carleton; María Lara-Tejero; Xiaoyun Liu; Jorge E Galán
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 9.  Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag.

Authors:  Nyasha Chin'ombe
Journal:  Viruses       Date:  2013-08-28       Impact factor: 5.048

10.  Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines.

Authors:  Nyasha Chin'ombe; Vurayai Ruhanya
Journal:  Open Virol J       Date:  2013-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.